Longitudinal Profiling Reveals Divergent Kidney and Brain Immune Responses during Metabolic Syndrome
Abstract
Chronic kidney disease (CKD) and cerebral small vessel disease (cSVD) share major cardiometabolic risk factors, including hypertension, diabetes, and obesity. The immune system may play a key role in kidney-brain interactions and disease development. However, whether circulating inflammatory mediators reflect similar immune responses in the kidney and brain remains unclear. We therefore characterized circulating, renal and cortical cerebral responses in a rat model of metabolic syndrome. Lean and Obese ZSF1 rats were studied at 8-9, 22-23, and 34-35 weeks of age. Systemic inflammation was assessed using multiplex plasma cytokine/chemokine analysis and flow cytometry of circulating immune cells. Kidney injury was evaluated by histopathology and expression of injury markers. Renal and cerebral blood flow were measured by Laser Speckle Contrast Imaging. Renal macrophage accumulation and cortical cerebral immune cell readouts were assessed by immunohistochemistry. Progression of metabolic syndrome in Obese ZSF1 rats was associated with elevated circulating inflammatory mediators, including IP-10, MCP-1, and RANTES, together with increased classical monocytes from 8-9 weeks and non-classical monocytes from 22-23 weeks onward. Kidney pathology was further characterized by progressive macrophage accumulation and reduced renal blood flow. In contrast, cortical cerebral analyses showed no evidence of macrophage infiltration, while CD68 positivity was reduced in Iba1+ microglia in Obese rats at 34-35 weeks. Despite marked systemic inflammation and renal immune activation, the cerebral cortex displayed a distinct immune response with no macrophage infiltration and altered microglial activity. Rather than indicating a uniform inflammatory response across organs, these descriptive findings provide insight into kidney-brain immune divergence during metabolic syndrome.
Related
- Blood Cytokine Profiling Reveals Distinct Inflammatory Signatures in Phenotypes A and B of Polyendocrine Metabolic Ovarian Syndrome (PMOS; formerly PCOS).
- Repeated Specific Health Guidance and improvement of metabolic syndrome in middle-aged working men: a longitudinal observational study using modified Poisson regression
- CREBBP variants underlying Menke-Hennekam syndrome exhibit histone acetyltransferase hyperactivity with divergent phase behaviors
- Glycemia reprograms substrate transport and shapes divergent stress responses in differentiating H9c2 cells
- Comparable Acute Antidepressant-like Effects of Two Subanesthetic Ketamine Doses Are Associated with Divergent Region-Specific Molecular Responses After Adolescent Chronic Stress
BibTeX
@article{taelen2026longitudinal,
title = {{Longitudinal Profiling Reveals Divergent Kidney and Brain Immune Responses during Metabolic Syndrome}},
author = {L van der Taelen and Smp Lambrichts and L Temmerman and R El Ajjouri and Mj Gijbels and N Bitsch and J Scheijen and M van de Waarenburg and M Kutmon and T Unger and J Staals and Cg Schalkwijk and Am Briones and Rj van Oostenbrugge and Sébastien Foulquier},
journal = {Aging and disease},
year = {2026},
month = oct,
doi = {10.14336/ad.2026.0557},
url = {https://hal.science/hal-05787298v1},
note = {CC BY},
}
RIS
TY - JOUR
TI - Longitudinal Profiling Reveals Divergent Kidney and Brain Immune Responses during Metabolic Syndrome
AU - L van der Taelen
AU - Smp Lambrichts
AU - L Temmerman
AU - R El Ajjouri
AU - Mj Gijbels
AU - N Bitsch
AU - J Scheijen
AU - M van de Waarenburg
AU - M Kutmon
AU - T Unger
AU - J Staals
AU - Cg Schalkwijk
AU - Am Briones
AU - Rj van Oostenbrugge
AU - Sébastien Foulquier
PY - 2026
DA - 2026/10/08
JO - Aging and disease
DO - 10.14336/ad.2026.0557
UR - https://hal.science/hal-05787298v1
AB - Chronic kidney disease (CKD) and cerebral small vessel disease (cSVD) share major cardiometabolic risk factors, including hypertension, diabetes, and obesity. The immune system may play a key role in kidney-brain interactions and disease development. However, whether circulating inflammatory mediators reflect similar immune responses in the kidney and brain remains unclear. We therefore characterized circulating, renal and cortical cerebral responses in a rat model of metabolic syndrome. Lean and Obese ZSF1 rats were studied at 8-9, 22-23, and 34-35 weeks of age. Systemic inflammation was assessed using multiplex plasma cytokine/chemokine analysis and flow cytometry of circulating immune cells. Kidney injury was evaluated by histopathology and expression of injury markers. Renal and cerebral blood flow were measured by Laser Speckle Contrast Imaging. Renal macrophage accumulation and cortical cerebral immune cell readouts were assessed by immunohistochemistry. Progression of metabolic syndrome in Obese ZSF1 rats was associated with elevated circulating inflammatory mediators, including IP-10, MCP-1, and RANTES, together with increased classical monocytes from 8-9 weeks and non-classical monocytes from 22-23 weeks onward. Kidney pathology was further characterized by progressive macrophage accumulation and reduced renal blood flow. In contrast, cortical cerebral analyses showed no evidence of macrophage infiltration, while CD68 positivity was reduced in Iba1+ microglia in Obese rats at 34-35 weeks. Despite marked systemic inflammation and renal immune activation, the cerebral cortex displayed a distinct immune response with no macrophage infiltration and altered microglial activity. Rather than indicating a uniform inflammatory response across organs, these descriptive findings provide insight into kidney-brain immune divergence during metabolic syndrome.
SN - 2152-5250
ER -